Ribociclib Plus Letrozole in Patients With Hormone Receptor‐positive, HER2‐negative Advanced Breast Cancer With No Prior Endocrine Therapy: Subgroup Analysis from the Phase 3b CompLEEment‐1 Trial: Subgroup Analysis of the CompLEEment‐1 Trial. Radiol Oncol 2022, 56 (2), 238-247.